DTC "skin longevity" skincare built around a proprietary OS-01 peptide, sold to a premium/biohacker-adjacent skincare audience, backed by roughly $42M in total funding to date, including a fresh $20M investment from Prelude Growth Partners in August 2025.

Creator-led, with a long-running paid-search anchor doing the category-ownership work in the background.

~343,000 estimated monthly visits (+7.5% over the last 3 months) as of 2026-07-13, an owned Instagram of 170,674 followers, a Google ad still active after ~965 days as of 2026-07-13, and press-reported 2025 revenue projection of $40-50M announced alongside the August 2025 raise.

As of 2026-07-13, the entire visible Meta ad set launched together on July 2, 2026, testing myth-busting peptide claims and hydration-stat social proof, while Google's newest tests probe educational search intent (retinol tapering, hyaluronic acid, microneedling alternatives).

OneSkin's acquisition splits cleanly by platform: Google search ads have anchored the "skin longevity" category for nearly three years while its own social accounts barely move the needle (X dormant since 2021, Instagram running roughly 0.1% engagement per post), so discovery is bought and borrowed from hired creators, not generated by the brand's own feed.